| Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran SH Hashemi, F Keramat, M Ranjbar, M Mamani, A Farzam, ... International journal of infectious diseases 11 (6), 496-500, 2007 | 124 | 2007 |
| Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates AM Bardbari, MR Arabestani, M Karami, F Keramat, MY Alikhani, ... Microbial pathogenesis 108, 122-128, 2017 | 102 | 2017 |
| Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran AHM Alizadeh, M Ranjbar, S Ansari, A MirArab, SM Alavian, ... EMHJ-Eastern Mediterranean Health Journal, 12 (5), 528-537, 2006, 2006 | 78 | 2006 |
| Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii AM Bardbari, MR Arabestani, M Karami, F Keramat, H Aghazadeh, ... European journal of clinical microbiology & infectious diseases 37, 443-454, 2018 | 76 | 2018 |
| Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial SH Hashemi, L Gachkar, F Keramat, M Mamani, M Hajilooi, A Janbakhsh, ... International Journal of Infectious Diseases 16 (4), e247-e251, 2012 | 74 | 2012 |
| TLR4 polymorphism in Iranian patients with brucellosis M Rezazadeh, M Hajilooi, A Rafiei, M Haidari, E Nikoopour, F Kerammat, ... Journal of infection 53 (3), 206-210, 2006 | 71 | 2006 |
| Comment on: epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran M Karami JOURNAL OF RESEARCH IN HEALTH SCIENCES (JRHS) 13 (1), 102-103, 2013 | 62 | 2013 |
| Comparison between doxycycline–rifampin–amikacin and doxycycline–rifampin regimens in the treatment of brucellosis M Ranjbar, F Keramat, M Mamani, AR Kia, SH Hashemi, M Nojomi International journal of infectious diseases 11 (2), 152-156, 2007 | 62 | 2007 |
| Assessment of health-related quality of life among patients with tuberculosis in Hamadan, Western Iran M Mamani, MM Majzoobi, SM Ghahfarokhi, F Esna-Ashari, F Keramat Oman medical journal 29 (2), 102, 2014 | 59 | 2014 |
| The current therapeutical strategies in human brucellosis M Bosilkovski, F Keramat, J Arapović Infection 49 (5), 823-832, 2021 | 57 | 2021 |
| Seroprevalence of brucellosis in butchers, veterinarians and slaughterhouse workers in Hamadan, western Iran M Mamani, MM Majzoobi, F Keramat, N Varmaghani, A Moghimbeigi Journal of research in health sciences 18 (1), 406, 2018 | 44 | 2018 |
| Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers P Adibi, R Ghassemian, SM Alavian, M Ranjbar, AH Mohammadalizadeh, ... Saudi Med J 25 (10), 1414-8, 2004 | 40 | 2004 |
| Human brucellosis in pregnancy–An overview M Bosilkovski, J Arapović, F Keramat Bosnian journal of basic medical sciences 20 (4), 415, 2020 | 39 | 2020 |
| Seroprevalence of hepatitis D virus and its risk factors in the west of Iran AHM Alizadeh, M Ranjbar, ASS Tehrani, F Keramat, M Mamani, ... Journal of Microbiology, Immunology and Infection 43 (6), 519-523, 2010 | 38 | 2010 |
| A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis F Keramat, M Ranjbar, M Mamani, SH Hashemi, F Zeraati Tropical doctor 39 (4), 207-210, 2009 | 37 | 2009 |
| Seroprevalence of HIV, HBV and HCV in persons referred to hamadan behavioral counseling center, west of Iran F Keramat, P Eini, MM Majzoobi Iranian Red Crescent Medical Journal 13 (1), 42, 2011 | 35 | 2011 |
| Association of susceptibility to brucellosis and interleukin-4 promoter polymorphism M Rezazadeh, M Hajilooi, M Haidari, A Rafiei, S Ahmad Alavi, F Keramat Scandinavian journal of infectious diseases 38 (11-12), 1045-1049, 2006 | 29 | 2006 |
| Effect of hydroxychloroquine on treatment and recurrence of acute brucellosis: a single-blind, randomized clinical trial MM Majzoobi, SH Hashemi, M Mamani, F Keramat, J Poorolajal, ... International journal of antimicrobial agents 51 (3), 365-369, 2018 | 27 | 2018 |
| Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran F Keramat, SH Hashemi, M Mamani, M Ranjbar, H Erfani East Mediterr Health J 14 (4), 768-75, 2008 | 27 | 2008 |
| Distribution of Class B and Class A β-Lactamases in Clinical Strains of Pseudomonas aeruginosa: Comparison of Phenotypic Methods and High-Resolution … S Dehbashi, H Tahmasebi, MY Alikhani, F Keramat, MR Arabestani Infection and Drug Resistance, 2037-2052, 2020 | 26 | 2020 |
Mojgan MamaniHamadan University of Medical Sciences在 umsha.ac.ir 的电子邮件经过验证
